Evidence map›Paper›PMID 25897749›Full record

ArticlePloS one2015

Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells.

Sudipta Tripathi, Lola Chabtini, Pranal J Dakle, Brian Smith, Hisaya Akiba, Hideo Yagita, Indira Guleria

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. T-bet Fate Mapping Reveals Gestational Stage-Specific Transcriptional Adaptation of Decidual NK Cells.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action.International journal of molecular sciences · 2017
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sudipta TripathiChildren's Hospital Boston, Renal Division, Harvard Medical School, Boston, Massachusetts, United States of America.
Lola ChabtiniChildren's Hospital Boston, Renal Division, Harvard Medical School, Boston, Massachusetts, United States of America.
Pranal J DakleChildren's Hospital Boston, Renal Division, Harvard Medical School, Boston, Massachusetts, United States of America.
Brian SmithChildren's Hospital Boston, Renal Division, Harvard Medical School, Boston, Massachusetts, United States of America.
Hisaya AkibaDepartment of Immunology, Juntendo University, Tokyo, Japan.
Hideo YagitaDepartment of Immunology, Juntendo University, Tokyo, Japan.
Indira GuleriaChildren's Hospital Boston, Renal Division, Harvard Medical School, Boston, Massachusetts, United States of America.
Boston Children's Hospital · USHarvard University · USJuntendo University · JP

Funding

Regulatory Costimulatory Pathways & Fetomaternal ToleranceR01AI084756 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI GULERIA, INDIRA · 2009 to 2012
$1.5M
Role of ICOS-B7h Regulatory Costimulatory Pathway in Fetomaternal ToleranceR21AI076794 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI GULERIA, INDIRA · 2009 to 2010
$470k
NIAID NIH HHS R01 AI084756NIAID NIH HHS R01 AI 84756-01A2NIAID NIH HHS R21 AI076794NIAID NIH HHS R21AI076794
6 · The paper itself

Abstract

NK cells are the most abundant lymphocyte population in the feto-maternal interface during gestation. The uterine NK cells (uNK) are transient, have a unique immunophenotype and produce a number of cytokines. These cytokines play an important role in establishment and maintenance of vascular remodeling and tolerance associated with successful pregnancy. The uNK cells also express TIM-3 during gestation and blockade of TIM-3 expression results in fetal loss in mice. In this study we determined the effect of TIM-3 blockade on uNK cells. Specifically we observed surface receptor phenotype and cytokine production by uNK cells following TIM-3 blockade. Our results show that TIM-3 plays a role in regulating the uNK cells and contributes to the maintenance of tolerance at the feto-maternal interface.

Indexed as

AnimalsAntigens, LyCD11b AntigenCells, CulturedChemokinesFemaleGranulocyte-Macrophage Colony-Stimulating FactorHepatitis A Virus Cellular Receptor 2Histocompatibility, Maternal-FetalImmune ToleranceImmunophenotypingInterleukin-15Killer Cells, NaturalMaleMice, Inbred C57BLMice, Inbred CBAAntigens, LyCD11b AntigenChemokinesGranulocyte-Macrophage Colony-Stimulating FactorHavcr2 protein, mouseHepatitis A Virus Cellular Receptor 2Interleukin-15Ly6 protein, mouseReceptors, Virus

Identifiers

PMID25897749
PMCPMC4405344
OpenAlexW2070470244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.